Second Laser Treatment for Glaucoma After Previous Laser Surgery
Part of Eyes & vision clinical trials.
This trial tests a new type of laser treatment (DSLT) for patients with glaucoma or high eye pressure who have already had a similar laser treatment (SLT) before. The goal is to see if this new laser approach can lower eye pressure in patients where the first treatment may not have worked well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Diagnosed with glaucoma (open-angle type) or ocular hypertension (high eye pressure without glaucoma damage)
- Already had selective laser trabeculoplasty (SLT) treatment in the past
- Eye pressure between 18–32 mm Hg when measured off all glaucoma medications
- No major eye surgeries besides SLT (such as cataract surgery in the last 2 years, trabeculectomy, or drainage implants)
- No secondary glaucoma from trauma, closed angles, or other diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This trial tests a laser treatment called DSLT in people recently diagnosed with open-angle glaucoma who have never had any other glaucoma treatment. It aims to see how well the laser lowers eye pressure.
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
This study compares a new way of doing laser treatment for open-angle glaucoma versus the standard method. The goal is to see which approach works better at lowering eye pressure and protecting vision.
This trial tests a type of laser treatment (DSLT) for people of Asian descent who have normal tension glaucoma, where eye pressure stays below 21 mmHg. It aims to see if this laser can help control the disease and possibly reduce the need for eye drops.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
Hear when a new Ocular Hypertension Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.